MacroGenics, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
MGNX Company Description
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 × CTLA-4), Tebotelimab (PD-1 × LAG-3), MGD024 (CD123 × CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV × CD3).
MGNX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view MGNX Smart Score
Score Breakdown
MGNX Company Description
Show More
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 × CTLA-4), Tebotelimab (PD-1 × LAG-3), MGD024 (CD123 × CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV × CD3). Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of MGNX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MGNX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on MGNX's company Twitter account
WallStreetBets
Number of mentions of MGNX in WallStreetBets Daily Discussion
MGNX News
Recent insights relating to MGNX
CNBC Recommendations
Recent picks made for MGNX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in MGNX
Corporate Flights
Flights by private jets registered to MGNX
Our Analysis